Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08
The equity awards cover 40,768 common shares, with vesting tied to continued service over three years.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Teladoc Health (NYSE:TDOC) granted inducement awards to three new employees effective November 1, 2026, in connection with its acquisition of Teledigm Health.
The restricted stock units cover 40,768 common shares and vest over three years, subject to continued service. The board’s Compensation Committee approved the awards under the company’s 2023 Employment Inducement Incentive Award Plan pursuant to New York Stock Exchange Rule 303A.08.
Positive
- None.
Negative
- Minor point. Forward-looking: it has not happened yet and may not happen.Restricted stock units covering 40,768 common shares create potential dilution as they vest over three years.
Key Figures
- Restricted stock units
- 40,768 shares
- Aggregate award to three Teledigm Health employees
- Vesting period
- Three years
- Based on continued service to Teladoc Health
- Employees receiving awards
- 3 employees
- Teledigm Health employees
Key Terms
restricted stock units financial
par value financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
NEW YORK, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued inducement awards to three new employees.
Effective November 1, 2026, in connection with the acquisition of Teledigm Health, LLC, three employees of Teledigm Health were granted awards of restricted stock units covering an aggregate of 40,768 shares of Teladoc Health’s common stock, par value
The awards were approved by the Compensation Committee of the Board of Directors of Teladoc Health and were granted under the Teladoc Health, Inc. 2023 Employment Inducement Incentive Award Plan as employment inducement awards pursuant to New York Stock Exchange Rule 303A.08.
About Teladoc Health
Teladoc Health (NYSE: TDOC) is the global leader in virtual care. The company is delivering and orchestrating care across patients, care providers, platforms, and partners — transforming virtual care into a catalyst for how better health happens. Through our relationships with health plans, employers, providers, health systems and consumers, we are enabling more access, driving better outcomes, extending provider capacity and lowering costs. Learn more at www.teladochealth.com.
Media:
Lou Serio
202-569-9715
PR@teladochealth.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.